Biosimilars Social Media
Found 36 results for "Biosimilars"Biosimilars Hashtags 3 of 36
| Hashtag | Type | Description |
|---|---|---|
| #JPM2020 | Healthcare Conferences | Biosimilars, biotech, healthcare, healthcare innovation, investment, investors, pharma, research The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together in… |
| #biosimilars | Regular | Biosimilars, follow-on biologics, pharmaceutical, subsequent entry biologics |
| #biosimilar | Regular | Biosimilars |
| #MERC17 | Healthcare Conferences | Biosimilars, drug development, ectd, ministries of health, pharmacovigilance, regulatory affairs, serialization DIA Middle East Regulatory Conference (MERC). Nov. 21-22, 2017. MERC brings together stakeholders to share regulatory advancements and best practices … |
| #DIABIOSIM | Healthcare Conferences | Biosimilars, global regulatory developments, interchangeable biologics With the approval of the first biosimilars in the US and the expiration of patents for originator biologicals, the market for biosimilars is poised to… |
| #DIALabeling16 | Healthcare Conferences | Biosimilars, Combination Products, Medical Affairs and Communications, medical writing, Patient Safety, pharmacovigilance, Quality Control, regulatory affairs Global Labeling 2016: Essential Updates on Worldwide Regulations and Guidelines, Sept. 12-13, Washington, D.C. This conference provides a forum for re… |
| #BOPA17 | Healthcare Conferences | Biosimilars, drug pricing, healthcare social media, hematologic malignancies, Hematology, Lung Cancer, Lungs, Oncology, pharmacy |
| #EGA21 | Healthcare Conferences | Biosimilars, conference, EGA, Europe, generic medicines, generics, patients, pharma Generic and Biosimilar medicines: 2020 Vision Leading on health equality and sustainable access to medicines for European patients Hilton Hotel, Berli… |
| #DIABiosimilars2016 | Healthcare Conferences | Biosimilars DIA Biosimilars 2016, October 27-28, Washington, DC. This conference will address biosimilars science, global regulatory pathways, evidence for clini… |
